BioSig Technologies [BSGM] vs Stryker [SYK] Detailed Stock Comparison

BioSig Technologies Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: BioSig Technologies Inc. wins in 1 metrics, Stryker Corporation wins in 16 metrics, with 1 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric BioSig Technologies Inc. Stryker Corporation Better
P/E Ratio (TTM) -4.97 39.21 Stryker Corporation
Price-to-Book Ratio -29.71 5.62 Stryker Corporation
Debt-to-Equity Ratio 0.00 72.97 Tie
PEG Ratio -0.03 0.72 Stryker Corporation
EV/EBITDA -7.24 19.90 Stryker Corporation
Profit Margin (TTM) 0.00% 12.92% Stryker Corporation
Operating Margin (TTM) -211,407.70% 27.24% Stryker Corporation
EBITDA Margin (TTM) N/A 27.24% N/A
Return on Equity 739.31% 15.08% BioSig Technologies Inc.
Return on Assets (TTM) -30.45% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-4.76M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return -73.04% -20.27% Stryker Corporation
Price-to-Sales Ratio (TTM) 16,550.19 5.02 Stryker Corporation
Enterprise Value $194.33M $138.30B Stryker Corporation
EV/Revenue Ratio 14,948.37 5.51 Stryker Corporation
Gross Profit Margin (TTM) N/A 64.54% N/A
Revenue per Share (TTM) $0 $66 Stryker Corporation
Earnings per Share (Diluted) $-1.05 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.82 0.93 Stryker Corporation
Short % of Float 5.91% 1.20% Stryker Corporation

BioSig Technologies Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

BSGM
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
BioSig Technologies Inc.0.00%17.97%77.65%-31.67%-63.79%-51.45%
Stryker Corporation0.58%-3.58%1.42%-23.29%-19.39%-15.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
BioSig Technologies Inc.-73.04%-88.56%-95.75%-96.61%-98.27%-98.27%
Stryker Corporation-20.27%9.63%21.15%168.66%406.79%583.29%

Performance & Financial Health Analysis: BioSig Technologies Inc. vs Stryker Corporation

MetricBSGMSYK
Market Information
Market Cap i$136.50M$126.25B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i784,1131,881,406
90 Day Avg. Volume i1,297,8422,161,139
Last Close$1.51$295.00
52 Week Range$0.70 - $14.11$281.00 - $404.87
% from 52W High-89.30%-27.14%
All-Time High$124.30 (May 11, 2020)$406.19 (Jan 27, 2025)
% from All-Time High-98.79%-27.37%
Growth Metrics
Quarterly Revenue GrowthN/A0.11%
Quarterly Earnings Growth-1.00%0.56%
Financial Health
Profit Margin (TTM) i0.00%0.13%
Operating Margin (TTM) i-2,114.08%0.27%
Return on Equity (TTM) i7.39%0.15%
Debt to Equity (MRQ) i0.0072.97
Cash & Liquidity
Book Value per Share (MRQ)$-0.12$58.61
Cash per Share (MRQ)$0.09$10.71
Operating Cash Flow (TTM) i$-4,356,000$5.04B
Levered Free Cash Flow (TTM) i$110.50M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: BioSig Technologies Inc. vs Stryker Corporation

MetricBSGM (Nov 18, 2025)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-4.9739.21
Forward P/E i-8.0319.67
PEG Ratio i-0.030.72
Price to Sales (TTM) i16,550.195.02
Price to Book (MRQ) i-29.715.62
Market Capitalization
Market Capitalization i$136.50M$126.25B
Enterprise Value i$194.33M$138.30B
Enterprise Value Metrics
Enterprise to Revenue i14,948.375.51
Enterprise to EBITDA i-7.2419.90
Risk & Other Metrics
Beta i1.820.93
Book Value per Share (MRQ) i$-0.12$58.61

Financial Statements Comparison: BioSig Technologies Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBSGM (2024)SYK (2025)
Revenue/Sales i40,00025.12B
Cost of Goods Sold iN/A9.05B
COGS % of Revenue i0.0%36.0%
Gross Profit iN/A16.07B
Gross Margin i0.0%64.0%
Research & Development i832,0001.62B
Operating Income (EBIT) i-12.61M5.06B
Operating Margin i-31,522.5%20.1%
EBITDA i-14.68M6.48B
EBITDA Margin i-36,697.5%25.8%
Pre-Tax Income i-10.34M4.51B
Pre-Tax Income % of Revenue i-25,847.5%18.0%
Income Tax i01.27B
Income Tax % of Revenue i0.0%5.0%
Net Income (Profit) i-10.34M3.25B
Profit Margin i-25,847.5%12.9%

Balance Sheet & Liquidity Metrics

MetricBSGM (2024)SYK (2025)
Cash & Equivalents i142,0004.01B
Total Current Assets i344,00014.76B
Total Current Assets % of Revenue i860.0%58.7%
Total Current Liabilities i2.26M7.79B
Total Current Liabilities % of Revenue i5,660.0%31.0%
Long-Term Debt i014.86B
Long-Term Debt % of Revenue i0.0%59.2%
Total Shareholders Equity i-1.42M22.42B
Retained Earnings i-255.35M20.47B
Retained Earnings % of Revenue i-638,362.5%81.5%
Property, Plant & Equipment i818,0001.79B

Cash Flow Statement Comparison

MetricBSGM (2024)SYK (2025)
Operating Cash Flow i-3.22M4.70B
Operating Cash Flow % of Revenue i-8,042.5%18.7%
Capital Expenditures i0-761.00M
Free Cash Flow i-4.76M4.28B
FCF Margin i-11,895.0%17.1%
Debt Repayment iN/A-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBSGMSYK
Shares Short i1.75M4.42M
Short Ratio i2.241.95
Short % of Float i5.91%1.20%
Shares Outstanding i30.79M382.50M
Float Shares i25.53M346.55M
% Held by Insiders i28.73%5.37%
% Held by Institutions i28.66%82.09%
% Held by Public i42.61%12.54%

Dividend Analysis & Yield Comparison: BioSig Technologies Inc. vs Stryker Corporation

MetricBSGMSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025